Literature DB >> 20169391

Variable intrafamilial expressivity of the rare tumor necrosis factor-receptor associated periodic syndrome-associated mutation I170N that affects the TNFR1A cleavage site.

Petra Lehmann1, Bernd Salzberger, Peter Haerle, Ivona Aksentijevich, Daniel Kastner, Juergen Schoelmerich, Stephanie Rosenfeld, Ulf Mueller-Ladner.   

Abstract

We report on a 33-year-old female patient with a relatively mild clinical case of TNF-receptor associated periodic syndrome (TRAPS) and her 58-year-old father in whom end-stage renal disease due to TRAPS-related AA-amyloidosis has already developed. TRAPS was caused by a I170N mutation that has previously not been associated with amyloidosis. It remains unclear if an only mildly affected patient such as ours would benefit from treatment considering her father's severe course of disease. The relevant literature on this problem is reviewed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20169391      PMCID: PMC3074501          DOI: 10.1007/s10165-010-0273-y

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN: 1439-7595            Impact factor:   3.023


  27 in total

1.  Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes.

Authors:  M F McDermott; I Aksentijevich; J Galon; E M McDermott; B W Ogunkolade; M Centola; E Mansfield; M Gadina; L Karenko; T Pettersson; J McCarthy; D M Frucht; M Aringer; Y Torosyan; A M Teppo; M Wilson; H M Karaarslan; Y Wan; I Todd; G Wood; R Schlimgen; T R Kumarajeewa; S M Cooper; J P Vella; C I Amos; J Mulley; K A Quane; M G Molloy; A Ranki; R J Powell; G A Hitman; J J O'Shea; D L Kastner
Journal:  Cell       Date:  1999-04-02       Impact factor: 41.582

2.  Treatment of the nephrotic syndrome with etanercept in patients with the tumor necrosis factor receptor-associated periodic syndrome.

Authors:  E Drewe; E M McDermott; R J Powell
Journal:  N Engl J Med       Date:  2000-10-05       Impact factor: 91.245

3.  Treatment of renal amyloidosis with etanercept in tumour necrosis factor receptor-associated periodic syndrome.

Authors:  E Drewe; M L Huggins; A G Morgan; M J D Cassidy; R J Powell
Journal:  Rheumatology (Oxford)       Date:  2004-08-17       Impact factor: 7.580

4.  Tumour necrosis factor receptor associated periodic syndrome (TRAPS) with central nervous system involvement.

Authors:  K Minden; E Aganna; M F McDermott; A Zink
Journal:  Ann Rheum Dis       Date:  2004-10       Impact factor: 19.103

5.  Prospective study of anti-tumour necrosis factor receptor superfamily 1B fusion protein, and case study of anti-tumour necrosis factor receptor superfamily 1A fusion protein, in tumour necrosis factor receptor associated periodic syndrome (TRAPS): clinical and laboratory findings in a series of seven patients.

Authors:  E Drewe; E M McDermott; P T Powell; J D Isaacs; R J Powell
Journal:  Rheumatology (Oxford)       Date:  2003-02       Impact factor: 7.580

6.  Monocytic fasciitis: a newly recognized clinical feature of tumor necrosis factor receptor dysfunction.

Authors:  Keith M Hull; Kondi Wong; Geryl M Wood; Wei-Sing Chu; Daniel L Kastner
Journal:  Arthritis Rheum       Date:  2002-08

7.  Tumor necrosis factor receptor 1-associated periodic syndrome without fever: cytokine profile before and during etanercept treatment.

Authors:  H Morbach; P Richl; S Stojanov; P Lohse; Hermann J Girschick
Journal:  Rheumatol Int       Date:  2009-12       Impact factor: 2.631

8.  Small vessel vasculitis and relapsing panniculitis in tumour necrosis factor receptor associated periodic syndrome (TRAPS).

Authors:  P Lamprecht; F Moosig; S Adam-Klages; U Mrowietz; E Csernok; M Kirrstetter; K Ahmadi-Simab; J O Schroder; W L Gross
Journal:  Ann Rheum Dis       Date:  2004-11       Impact factor: 19.103

Review 9.  The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder.

Authors:  Keith M Hull; Elizabeth Drewe; Ivona Aksentijevich; Harjot K Singh; Kondi Wong; Elizabeth M McDermott; Jane Dean; Richard J Powell; Daniel L Kastner
Journal:  Medicine (Baltimore)       Date:  2002-09       Impact factor: 1.889

10.  Tumor necrosis factor receptor-associated periodic syndrome characterized by a mutation affecting the cleavage site of the receptor: implications for pathogenesis.

Authors:  Martin A Kriegel; Ulrike Hüffmeier; Elisabeth Scherb; Christina Scheidig; Thomas Geiler; Joachim R Kalden; André Reis; Hanns-Martin Lorenz
Journal:  Arthritis Rheum       Date:  2003-08
View more
  2 in total

Review 1.  Tumor necrosis factor-associated periodic syndrome in adults.

Authors:  Sharika Gopakumar Menon; Petros Efthimiou
Journal:  Rheumatol Int       Date:  2017-09-23       Impact factor: 2.631

2.  Evidence for genetic overlap between adult onset Still's disease and hereditary periodic fever syndromes.

Authors:  R Sighart; J Rech; A Hueber; N Blank; S Löhr; A Reis; H Sticht; U Hüffmeier
Journal:  Rheumatol Int       Date:  2017-11-20       Impact factor: 2.631

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.